- Absoludy COVID-19 Neutralizing Antibody for ABSOL use is based on the principle of Fluorescence immunoassay detecting semi-quantitative value of SARS-CoV-2 Virus’s neutralizing antibody.

-Measuring the level of COVID-19 Neutralizing Antibody is to help check the overall vaccine efficacy, compare efficacy of different vaccine candidates, monitor longevity of protective immunity and lead to herd immunity.

• Performance

< Total Results for COVID-19 NAb Clinical Agreement >

Clinical Sensitivity: 100%

Clinical Specificity: 100%

• Procedure *Sample: Serum or Plasma(heparin, K₂-EDTA), 40μL

• Result & Interpretation

The result of two CH. is determined by ABSOL Cut-off Index (COI)

Test result is negative if COI is< 1.0 and positive if COI is ≥1.0 (Negative <1.0, Positive ≥1.0)

< Negative >                         

 < Positive>